Company led recall

Aspar Pharmaceuticals have informed AHDL of an issue causing Partial blister deformation and perforation on blister packs

Product recall date: 29/01/26

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

Please note that anything not returned to us, or notified to us, within 3 months of this notification, cannot be reimbursed by way of a credit.

National Patient Safety Alert: Class 1 Medicines Recall Notification: Recall of Quetiapine Oral Suspension (unlicensed medicine)

Eaststone Limited is initiating a recall of all batches of quetiapine oral suspension products due to a potential risk of overdose, which could have consequences for the safety of patients.

MHRA Drug alert date: 29/01/26

MHRA drug alert link: https://www.gov.uk/drug-device-alerts/national-patient-safety-alert-class-1-medicines-recall-notification-recall-of-quetiapine-oral-suspension-unlicensed-medicine-manufactured-by-eaststone-limited-due-to-a-potential-for-overdosing-natpsa-slash-2026-slash-002-slash-mhr?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=a09ef640-89c2-4758-9ee1-2f562cdba868&utm_content=immediately#download-documents

Eaststone Limited will be contacting customers who have received affected stock directly

Further Information

For more information or stock and, please contact Eaststone Limited on +44(0)800 678 3102 (Select Option 1) or email specials@eaststone.co.uk 

For medical information queries, please contact Eaststone Limited on +44(0)800 678 3102 (Select Option 3) or email umar.ahmed@eaststone.co.uk 

For all other enquires place contact Eaststone Limited +44(0)800 678 3102 (Select Option 3) or email umar.ahmed@eaststone.co.uk 

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

Please note that anything not returned to us, or notified to us, within 3 months of this notification, cannot be reimbursed by way of a credit.

Class 4 caution in use-Arixtra solution for injection, pre-filled syringes

Viatris has received reports of brown discolouration and blockage in the needle of pre-filled syringes of Arixtra. This quality defect is related to oxidation of the syringe needle.

MHRA drug alert Date: 28/1/26

MHRA drug alert link: Class 4 Medicines Defect Notification: Viatris Products Ltd, Arixtra solution for injection, pre-filled syringes, EL(26)A/04 - GOV.UK

This is a caution in use only we are not accepting stock returns

Further Information

For medical information enquiries please telephone Viatris UK Healthcare Limited Medical Information on +44 (0)1707 853 000 (select option 1) or email info.uk@viatris.com.

For stock control enquiries please contact telephone Customer Services on +44 (0)1707 853 000 (select option 2).

Class 4 caution in use-Ocumont Eye Ointment 1% w/w

Blumont Pharma Limited is reporting to the MHRA regarding the absence of Braille on the outer carton of one batch of Ocumont Eye Ointment 1% w/w (POM). It was identified that the Braille information was inadvertently omitted during the approval and release process.

MHRA drug alert Date: 27/1/26

MHRA drug alert link: Class 4 Medicines Defect Notification: Blumont Pharma Limited, Ocumont Eye Ointment 1% w/w, EL(26)A/03 - GOV.UK

This is a caution in use only we are not accepting stock returns

further information

For all medical information enquiries and information on this product, please email info@blumontpharma.com, or telephone + 44 (0)1476 978 568.

For stock control enquiries please email info@blumontpharma.com, or telephone + 44 (0)1476 978 568.

Class 3 recall- Fingolimod Glenmark 0.5 mg Hard Capsules

CLASS 3 RECALL

PLEASE READ AND CONFIRM THAT YOU HAVE RECEIVED THIS.

We have received a Class 3 Recall from Glenmark Pharmaceuticals Europe Limited on FINGOLIMOD CAP 0.5MG

MHRA drug alert link https://www.gov.uk/drug-device-alerts/class-3-medicines-recall-glenmark-pharmaceuticals-europe-limited-fingolimod-glenmark-0-dot-5-mg-hard-capsules-el-26-a-slash-02?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=53be9484-a57c-41df-9fe0-10338d61497b&utm_content=immediately

MHRA ref: DMRC-38142990

Reason: Glenmark Pharmaceuticals Europe Limited is recalling the above batch after stability testing showed out-of-specification results. The batch is being recalled as a precautionary measure following test results that showed a delay in capsule dissolution.

Please can you ensure that your stores quarantine the product listed below.

Further Information

For all medical information enquiries and information on this product, medical_information@glenmarkpharma.com or telephone 0044 8004 580 383

For stock control enquiries please email orders.uk@glenmarkpharma.com

Please return all affected stock to your original supplier for credit. As Alliance Healthcare has not supplied the affected batch, we will not be accepting returns.

Please note that anything not returned to us, or notified to us, within 3 months of this notification, cannot be reimbursed by way of a credit.

Class 2 recall-Paliperidone PR pre-filled syringe 50, 75, 100 & 150mg

Mercury Pharmaceuticals Ltd is recalling remaining stock of paliperidone pre-filled syringes as a precautionary measure due to Good Manufacturing Practice (GMP) deficiencies cited during a recent inspection at the finished product manufacturing site.

MHRA drug alert link: https://www.gov.uk/drug-device-alerts/class-2-medicines-recall-mercury-pharmaceuticals-ltd-paliperidone-mercury-pharma-prolonged-release-suspension-for-injection-in-pre-filled-syringes-el-26-a-slash-01?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=e99da014-d03f-4b15-9aee-619b70601394&utm_content=immediately

MHRA drug alert date: 20/01/26

Further Information

For stock enquiries please contact Advanz Pharma Customer Care Services on +44 (0) 208 588 9441 or email customercare@advanzpharma.com

For medical information enquiries please contact Advanz Pharma Medical Information on +44 (0) 208 588 9131 or email medicalinformation@advanzpharma.com

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

Please note that anything not returned to us, or notified to us, within 3 months of this notification, cannot be reimbursed by way of a credit.

Nestle SMA Infant Milk - Food Standards Agency Consumer Recall Notice

Retailers of these products must display the recall notice from Nestle which can be found using this link.

Product recall date: 06/01/26

Nestlé recalls several SMA Infant Formula and Follow-On Formula as a precaution because of the possible presence of cereulide (toxin) | Food Standards Agency

Company led recall-Nestle Multiple

Nestle have detected a quality defect in an ingredient from a supplier

Product recall date 06/01/26

Further Information

https://www.nestle.co.uk/en-gb/getintouch

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

Please note that anything not returned to us, or notified to us, within 3 months of this notification, cannot be reimbursed by way of a credit.

Company led recall- SMA Alfamino

Nestle have detected a quality defect in an ingredient from a supplier

Product recall date 06/01/26

Further Information

https://www.nestle.co.uk/en-gb/getintouch

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

Please note that anything not returned to us, or notified to us, within 3 months of this notification, cannot be reimbursed by way of a credit.

Class 3 recall-Prednisolone 5mg soluble tabs

Activase Pharmaceuticals Limited is recalling two batches of Prednisolone 5mg Soluble Tablets as a precautionary measure due to a limited number of reports of blister pockets becoming swollen over time.

MHRA drug alert link https://www.gov.uk/drug-device-alerts/class-3-medicines-recall-activase-pharmaceuticals-limited-prednisolone-5mg-soluble-tablets-el-25-a-slash-54?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=1366bdc1-73bc-4d3f-b72b-aa21c0cdac67&utm_content=immediately

MHRA drug alert date 15/12/25

Further Information

For all medical information enquiries and information on this product, please email eupvg@genreg.eu or telephone 020 72010421.

For stock control enquiries please email info@genesis-pharma.com or telephone 0207 2010400.

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

Please note that anything not returned to us, or notified to us, within 3 months of this notification, cannot be reimbursed by way of a credit.